𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Who will pay for intercalated degrees in pathology?

✍ Scribed by Carl Gray

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
262 KB
Volume
157
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Commentary: The benefits of collaboratio
Commentary: The benefits of collaboration in research: who will pay?
✍ Barbara Dickey; Ph.D. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 18 KB πŸ‘ 1 views

Collaboration between MCOs and researchers holds promise for benefiting consumers by working on quality-of-care-related research. There are at least three areas of collaboration that might benefit both researchers and MCOs: (1) the developing and validating of management and fiscal indicators, (2) d

How much are customers willing to pay fo
How much are customers willing to pay for improvements in health and environmental quality?
✍ Lisa L. Wood; Anne E. Kenyon; William H. Desvousges; Lyn K. Morander πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier Science 🌐 English βš– 785 KB

Collecting data via computer interviews and using conjoint analysis provided Wisconsin utilities with data about customers" stated willingness to pay/or environmental, energy, and health outcomes. Studies that involve the customer in this manner can provide timely, useful information to electric uti

Who will teach an integrated program for
Who will teach an integrated program for science and technology in Israeli junior high schools?: A case study
✍ Moshe Barak; Shiri Pearlman-Avnion πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 3 views

The teachers' role in the integration of science and technology studies within the recent educational reform in Israeli junior high schools was addressed within a case study. Eight science teachers and three technology teachers participated in in-service training courses and received individual tuto

Who will be eligible? An investigation o
Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance
✍ Fiona E Matthews; Graciela Muniz-Terrera; Ian McKeith; Carol Brayne πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract ## Objectives Investigate the impact of the changes in eligibility within England and Wales (E&W) for prescription within the UK National Health Service for treatment of Alzheimer's disease (AD). ## Methods A population‐based study in England and Wales with 13 004 individuals measure